Prarthana Gopal is an Author at Android Police. With over eight years of experience as a professional author and tech enthusiast, she brings a wealth of expertise to this role. Currently, she ...
The ROG Ally burst onto the scene in 2023 as a great alternative to the Steam Deck, offering access to even more games thanks to it running on a Windows operating system. Last year saw the release of ...
Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate ...
Daiichi Sankyo and AstraZeneca have pressed swiftly to file for approval of their TROP2-targeting drug Datroway for ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...
Scoggin Dickey’s new 6.6L SDRL8T LT crate engine is available in 598 hp and 636 hp configurations, both with CNC-ported heads ...
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce ...
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singaporean Health Sciences Authority (HSA) say the ...
A Texas Two-Step Bankruptcy helps companies manage legal liabilities. Discover its process, criticisms, and a detailed ...
Pharmaceutical Technology on MSN
UK slashes 2026 drug rebate rate by one-third to win back pharma sentiments
The UK's 14.5% drug rebate reduction may help to quell souring pharma sentiments, which stem from the nation's low spending on innovative drugs.
Pharmaceutical Technology on MSN
States consider payment limits to curb prescription drug prices with PDABs
At least five state committees in the US are exploring ways to enact independent measures to improve drug affordability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results